ALEXANDRIA, Va., June 5 -- United States Patent no. 12,276,655, issued on April 15, was assigned to NEXTCELL PHARMA AB (Huddinge, Sweden).
"MSC prediction algorithm" was invented by Mathias Gosta Svahn (Nacka, Sweden), Johanna Dahllund (Tullinge, Sweden) and Bahareh Khalaj (Sundbyberg, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of in vitroprediction of the in vivoefficacy in a patient of treatment with a drug product based on an overall assessment of the properties patients own immune cells when exposed to the drug product with and/0 or without stimulation; the drug product when exposed to said patients own immune cells; and any preexisting antibodies agai...